FindTrial
Sign In

Study on the clinical value of pregnancy promotion condoms (prodom) and pregnancy promotion kits in the treatment of male infertility

Research and application of key technologies of prodom and pregnancy promotion kits

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017133
Enrollment
Unknown
Registered
2018-07-13
Start date
2012-01-01
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male infertility

Interventions

the prodom-assisted treatment group:prodom
syringe-assisted treatment group:syringe
traditional treatment group:used 1,000 mg of vitamin C and 100 mg of vitamin E, which were administered every day, and 10 ml zinc gluconate and a spermatogenic tablet (traditional Chinese medicine) we

Sponsors

Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
21 Years to 48 Years

Inclusion criteria

Inclusion criteria: clinical records of all semen non-liquefaction patients and weak sperm disease patients (hospitalisations during January 1, 2012 to May 31, 2018) should be complete and accurate, and the follow-up visits lasted for 0.75-6 years.

Exclusion criteria

Exclusion criteria: 1. non-semen non-liquefaction; 2. organic diseases, including uraemia, cirrhosis and liver failure, lung failure, endocrine dysfunction, mental disorder, azoospermia, or severe oligospermia; 3. incomplete clinical records; 4. willing to terminal the treatment or refusing follow-up visits.

Design outcomes

Primary

MeasureTime frame
pregnancy rate;time to conception;treatment cost;—

Countries

China

Contacts

Public ContactZongping Chen

Affiliated Hospital of Zunyi Medical University

2404259310@qq.com+86 13508512561

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026